Rita J Desai

Array ( [id] => 7474042 [patent_doc_number] => 20040097425 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-20 [patent_title] => 'Peptide compounds' [patent_app_type] => new [patent_app_number] => 10/250444 [patent_app_country] => US [patent_app_date] => 2003-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26693 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20040097425.pdf [firstpage_image] =>[orig_patent_app_number] => 10250444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6112698 [patent_doc_number] => 20020173500 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-21 [patent_title] => 'Substituted heterocyclo-norbornylamino derivatives, processes for their preparation, their use as medicaments or diagnostics, and medicaments comprising them' [patent_app_type] => new [patent_app_number] => 10/020241 [patent_app_country] => US [patent_app_date] => 2001-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9337 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20020173500.pdf [firstpage_image] =>[orig_patent_app_number] => 10020241 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5875108 [patent_doc_number] => 20020049316 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-25 [patent_title] => 'Protease inhibitors' [patent_app_type] => new [patent_app_number] => 10/022713 [patent_app_country] => US [patent_app_date] => 2001-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37866 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20020049316.pdf [firstpage_image] =>[orig_patent_app_number] => 10022713 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6843702 [patent_doc_number] => 20030149049 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-07 [patent_title] => 'Small-molecule inhibitors of interleukin-2' [patent_app_type] => new [patent_app_number] => 10/024665 [patent_app_country] => US [patent_app_date] => 2001-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21725 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0149/20030149049.pdf [firstpage_image] =>[orig_patent_app_number] => 10024665 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7645575 [patent_doc_number] => 06472394 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-29 [patent_title] => 'MCH antagonists and their use in the treatment of obesity' [patent_app_type] => B1 [patent_app_number] => 10/023371 [patent_app_country] => US [patent_app_date] => 2001-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9999 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/472/06472394.pdf [firstpage_image] =>[orig_patent_app_number] => 10023371 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1313037 [patent_doc_number] => 06610685 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-08-26 [patent_title] => 'Fused indole derivatives' [patent_app_type] => B2 [patent_app_number] => 10/017978 [patent_app_country] => US [patent_app_date] => 2001-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17155 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/610/06610685.pdf [firstpage_image] =>[orig_patent_app_number] => 10017978 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6684004 [patent_doc_number] => 20030119868 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Gyrase inhibitors and uses thereof' [patent_app_type] => new [patent_app_number] => 10/015332 [patent_app_country] => US [patent_app_date] => 2001-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16714 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20030119868.pdf [firstpage_image] =>[orig_patent_app_number] => 10015332 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6766369 [patent_doc_number] => 20030100769 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-29 [patent_title] => 'Cyclic amidine compounds' [patent_app_type] => new [patent_app_number] => 10/009477 [patent_app_country] => US [patent_app_date] => 2001-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13839 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20030100769.pdf [firstpage_image] =>[orig_patent_app_number] => 10009477 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7436530 [patent_doc_number] => 20040002486 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-01 [patent_title] => 'Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation' [patent_app_type] => new [patent_app_number] => 10/013308 [patent_app_country] => US [patent_app_date] => 2001-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 22851 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20040002486.pdf [firstpage_image] =>[orig_patent_app_number] => 10013308 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1339031 [patent_doc_number] => 06593471 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-07-15 [patent_title] => 'Synthesis of heteroarylamine intermediate compounds' [patent_app_type] => B2 [patent_app_number] => 10/008927 [patent_app_country] => US [patent_app_date] => 2001-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6514 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 903 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/593/06593471.pdf [firstpage_image] =>[orig_patent_app_number] => 10008927 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6132048 [patent_doc_number] => 20020077475 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-20 [patent_title] => 'Novel synthesis of heteroarylamine intermediate compounds' [patent_app_type] => new [patent_app_number] => 10/010460 [patent_app_country] => US [patent_app_date] => 2001-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6730 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20020077475.pdf [firstpage_image] =>[orig_patent_app_number] => 10010460 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5875138 [patent_doc_number] => 20020049333 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-25 [patent_title] => 'Pyridine intermediate compound' [patent_app_type] => new [patent_app_number] => 10/008979 [patent_app_country] => US [patent_app_date] => 2001-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6703 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20020049333.pdf [firstpage_image] =>[orig_patent_app_number] => 10008979 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5859887 [patent_doc_number] => 20020123490 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-05 [patent_title] => 'Combination treatment for anxiety, depression, obsessive compulsive disorder and psychosis' [patent_app_type] => new [patent_app_number] => 10/010651 [patent_app_country] => US [patent_app_date] => 2001-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9029 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20020123490.pdf [firstpage_image] =>[orig_patent_app_number] => 10010651 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6017751 [patent_doc_number] => 20020103379 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-01 [patent_title] => 'Process for making a thrombin inhibitor' [patent_app_type] => new [patent_app_number] => 10/013063 [patent_app_country] => US [patent_app_date] => 2001-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7682 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20020103379.pdf [firstpage_image] =>[orig_patent_app_number] => 10013063 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5829461 [patent_doc_number] => 20020068826 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-06 [patent_title] => 'Novel synthesis of heteroarylamine intermediate compounds' [patent_app_type] => new [patent_app_number] => 10/010459 [patent_app_country] => US [patent_app_date] => 2001-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6717 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20020068826.pdf [firstpage_image] =>[orig_patent_app_number] => 10010459 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6439810 [patent_doc_number] => 20020128266 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-12 [patent_title] => 'ABCA-1 elevating compounds' [patent_app_type] => new [patent_app_number] => 10/005064 [patent_app_country] => US [patent_app_date] => 2001-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17297 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20020128266.pdf [firstpage_image] =>[orig_patent_app_number] => 10005064 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 668540 [patent_doc_number] => 07094781 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-22 [patent_title] => 'Sulfamides and their use as endothelin receptor antagonists' [patent_app_type] => utility [patent_app_number] => 10/433041 [patent_app_country] => US [patent_app_date] => 2001-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15980 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/094/07094781.pdf [firstpage_image] =>[orig_patent_app_number] => 10433041 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6766149 [patent_doc_number] => 20030100549 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-29 [patent_title] => 'Inhibitors of c-Jun N-terminal kinases (JNK)' [patent_app_type] => new [patent_app_number] => 10/008277 [patent_app_country] => US [patent_app_date] => 2001-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6148 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20030100549.pdf [firstpage_image] =>[orig_patent_app_number] => 10008277 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1205974 [patent_doc_number] => 06716844 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-04-06 [patent_title] => 'Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds' [patent_app_type] => B2 [patent_app_number] => 10/005437 [patent_app_country] => US [patent_app_date] => 2001-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28762 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/716/06716844.pdf [firstpage_image] =>[orig_patent_app_number] => 10005437 [rel_patent_id] =>[rel_patent_doc_number] =>)